Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
3 active Medicare policies list J3316, and 20 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Apr 1, 2026
20 policies from 11 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J3316 |
|---|---|---|
| Triptodur (triptorelin extended-release suspension) | Nov 1, 2025 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Triptodur (triptorelin extended-release suspension) | Nov 1, 2024 | Prior auth requiredInferred from policy title |
| Triptodur (triptorelin) | Nov 1, 2023 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | Apr 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | Jan 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | Jul 15, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | Dec 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | May 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) | Apr 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Triptorelin Extended-Release Suspension (Triptodur) - Oscar | Jun 1, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J3316 |
|---|---|---|
| Triptorelin (e.g., Triptodur, Trelstar) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin-Releasing Hormone (GnRH) Agonists and Antagonists | Aug 15, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Triptorelin (Triptodur) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Triptorelin pamoate (Trelstar, Triptodur); CP.PHAR.175 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |
| Policy | Effective | Status of J3316 |
|---|---|---|
| Gonadotropin Releasing Hormone Analogs | Jul 1, 2025 | Covered |